Skip to main content
Clinical Trials/IRCT20210205050247N1
IRCT20210205050247N1
Recruiting
Phase 1

A comparative study of the effect of olfactory training and vitamin A in the olfactory loss of patients with covid-19.

Bagheiat-allah University of Medical Sciences0 sites90 target enrollmentTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
olfactory loss.
Sponsor
Bagheiat-allah University of Medical Sciences
Enrollment
90
Status
Recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Bagheiat-allah University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Age between 20 and 65
  • No underlying disease including: hypertension, hypo and hyperthyroidism, seizures, diabetes, asthma, Bell's palsy
  • Continuation of olfactory reduction for more than two weeks

Exclusion Criteria

  • Patient dissatisfaction
  • Prolonged exposure to some chemicals agents (detergents)
  • History of head trauma
  • History of sinus surgery or septorhinoplasty, rhinoplasty, turbinectomy and radiation therapy
  • Having neurodegenerative disease (Alzheimer's, Parkinson, MS, epilepsy, seizures)
  • Having mental disorders (schizophrenia and depression)
  • Having neuropsychiatric disorders (autism, Asperger's, lack of concentration and hyperactivity)
  • History of repeated use of the following drugs:Metronidazole, benzocaine, clofibrate, amphotericin B, ampicillin, allopurinol, captopril, baclofen, codeine, carbamazepine and amphetamines.

Outcomes

Primary Outcomes

Not specified

Similar Trials